Agendia
Agendia is a molecular diagnostics company focused on breast cancer. It offers MammaPrint and BluePrint genomic tests, which the company describes as assessing recurrence risk and tumour biology to inform early-stage breast-cancer treatment planning.
Basic Information
- Category: business
- Website: http://www.agendia.com
Documented Facts
- Inception (Wikidata): 2003-01-01 (Source 2: Wikidata Q30284525, revision 2474422615)
- Headquarters location (Wikidata; date unspecified): Amsterdam (Source 2: Wikidata Q30284525, revision 2474422615; Source 3: Wikidata label: Q727, revision 2552147637)
- Country (Wikidata; date unspecified): Netherlands (Source 2: Wikidata Q30284525, revision 2474422615; Source 4: Wikidata label: Q55, revision 2556226405)
- Official website (Wikidata; date unspecified): http://www.agendia.com/ (Source 2: Wikidata Q30284525, revision 2474422615)
- Published focus: Genomic testing for early-stage breast cancer and its care teams (Recorded confidence: medium; Source 5: About Us - Agendia)
Products and Services
- MammaPrint and BluePrint: Genomic tests described by Agendia for assessment of breast-cancer recurrence risk and tumour biology.
Evidence and Sources
- Agendia — Official Site (official)
- Wikidata Q30284525, revision 2474422615 (knowledge-base)
- Wikidata label: Q727, revision 2552147637 (knowledge-base)
- Wikidata label: Q55, revision 2556226405 (knowledge-base)
- About Us - Agendia (official)
- Early Breast Cancer Treatment & Genomic Testing | Agendia (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Agendia.
- Canonical profile: https://brandsource.ai/brands/agendia
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/agendia/json-ld
- Citation profile API: https://brandsource.ai/api/brands/agendia/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Partial
- Profile completeness: Source-backed profile (91/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Agendia is a molecular diagnostics company focused on breast cancer. It offers MammaPrint and BluePrint genomic tests, which the company describes as assessing recurrence risk and tumour biology to inform early-stage breast-cancer treatment planning.
Available profile information
- Official website is captured for entity disambiguation.
- 3 official sources linked for verification.
- 3 supporting sources linked.
- 5 structured facts available for extraction.
- 1 product or service signal captured.
Known data gaps
- Profile enrichment is incomplete
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.